Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Apriglim MV 1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Aprica Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Apriglim MV 1 Tablet SR

Diabetic patients with type 2 diabetes mellitus may be prescribed the anti-diabetic medication, Apriglim MV 1 SR Tablet, a combination therapy for adults. This medication assists in regulating blood glucose. Administer this drug with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without consulting your doctor can lead to elevated blood sugar, potentially resulting in kidney complications, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management plan that incorporates a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to manage them promptly. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks, fruit juice) are essential precautions. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headaches, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Patients with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Apriglim MV 1 Tablet SR

No information provided. Therefore, no text can be rewritten.

Uses of Apriglim MV 1 Tablet SR

Managing type 2 diabetes

Major Benefits of Apriglim MV 1 Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Apriglim MV 1 Tablet SR on an empty stomach.

Common Side effects of Apriglim MV 1 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Apriglim MV 1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Apriglim MV 1 Tablet SR on an empty stomach.

How Apriglim MV 1 Tablet SR works:

Apriglim MV 1 sustained-release tablet contains a triple combination of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Apriglim MV 1 Tablet SR and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Apriglim MV 1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Apriglim MV 1 Tablet SR while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Apriglim MV 1 Tablet SR is likely unsafe for individuals with kidney impairment and should be avoided. Medical advice is recommended. Furthermore, its use is contraindicated in patients exhibiting severe kidney disease.

LiverLiverCAUTION

Exercise caution when prescribing Apriglim MV 1 Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician before administration. A reduced initial dose of Apriglim MV 1 Tablet SR is typically recommended for patients exhibiting mild to moderate liver disease; its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Apriglim MV 1 Tablet SR :

Should you forget a dose of Apriglim MV 1 Tablet SR, take it immediately if you remember. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Apriglim MV 1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Apriglim MV 1 Tablet SR

Apriglim MV 1 Tablet SR combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This triple-action therapy, used alongside diet and exercise, improves blood glucose control. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, while voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This medication is not suitable for type 1 diabetes.
Apriglim MV 1 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, taste changes, gas, stomach pain, headache, rash, and respiratory infection.
Apriglim MV 1 Tablet SR is contraindicated in patients with allergies to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Apriglim MV 1 Tablet SR and alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Apriglim MV 1 Tablet SR can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, following the storage instructions provided. Discard any unused medication properly and ensure it remains inaccessible to children, pets, and others.
Apriglim MV 1 Tablet SR
214
MRP 248
13% off